While mild symptoms are normal, severe or persistent discomfort should be discussed with your doctor
In general, glycemic control is an accepted concept in TBI management [27, 38], and supplementation with additional substrates such as lactate (intravenously or via CMD) may also show some clinical utility in reducing complications, like intracranial hypertension [44], when metabolic targets are better defined
This depends on factors like your goals, current online presence, and target audience
No, not if in their clinical judgement they determine that the compounding is clinically beneficial
Individuals who are overweight or obese (with a BMI of 25 or higher) or have one or more obesity-related conditions may be suitable candidates for GLP-1 therapy
Table 1 The summary of the neuroimmunological effects of omega-3 fatty acids on migraine